基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
The purpose of the present study was to study the characteristics of epidemic growth factor receptor(EGFR)gene distribution in patients with non-small cell lung cancer(NSCLC),and to detect the mutation rate of EGFR gene by Sanger sequencing and amplification refractory mutation system(ARMS)-PCR.Paraffin-embedded sections of NSCLC tissues from 399 NSCLC patients diagnosed in Renmin Hospital of Wuhan University were collected,103 of them were detected for exons 18-21 mutation of EGFR by Sanger sequencing method,296 cases were detected for exons 18-21 mutation by ARMS-PCR method.DNA extraction of both groups was performed with Qiagen QLAamp DNA FFPE Tissue KIT.Comparisons of detection rates between the two methods were conducted by row X list chi-square test.The total mutation rate of EGFR gene detected by Sanger sequencing was 21.4%,exons 18-21 and combined mutation rates were 1.0%,9.7%,1.0%,7.8%and 2.0%,respectively.And the proportions were 4.7%,45.2%,4.7%,36.3%and 9.4%respectively.The total mutation rate detected by ARMS-PCR was 51.4%,exons 18-21 and combined mutation rates were 2.7%,27%,1.7%,18.2%and 1.7%,respectively.The proportions were 5.3%,52.6%,3.3%,35.5%and 3.3%respectively.Further analysis of mutation rate showed that there was significant difference between the two methods in detecting total mutation of EGFR gene(P<0.001).There were significant differences in mutation detection rates of exons 19 and 21(P<0.001,P<0.05),but there were no significant differences in other exons.And there was no significant difference in mutation detection rates between the two methods.The mutation rate of EGFR gene in NSCLC patients was 50%.And exon 19 deletion was the most common mutation type,followed by exon 21 mutation.Compared with Sanger sequencing method,ARMS method is more sensitive with significant advantages in detecting exon 19 deletions and exon 21 mutations,which can be widely used in clinical detection of EGFR gene mutations.The results of this study will further guide patients with advanced NSCLC to select TKI
推荐文章
EGFR基因突变与非小细胞肺癌靶向治疗研究进展
非小细胞肺
受体
表皮生长因子
突变
药物疗法
EGFR基因20外显子插入突变在非小细胞肺癌的研究及其进展
表皮生长因子受体
20外显子
肺肿瘤
插入突变
EGFR突变非小细胞肺癌免疫治疗相关研究进展
肺肿瘤
表皮生长因子受体
免疫治疗
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer
来源期刊 当代医学科学(英文) 学科 医学
关键词 epidemic growth factor receptor targeted therapy amplification refratory mutation systePCR Sanger sequencing
年,卷(期) 2020,(1) 所属期刊栏目
研究方向 页码范围 78-84
页数 7页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
epidemic
growth
factor
receptor
targeted
therapy
amplification
refratory
mutation
systePCR
Sanger
sequencing
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
当代医学科学(英文)
双月刊
2096-5230
42-1898/R
13 Hangkonglu, Wuhan
38-56
出版文献量(篇)
138
总下载数(次)
1
总被引数(次)
0
论文1v1指导